R. Daniel Beauchamp

February 9, 2015

Gene profile predicts metastasis

A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.

By Yan Su
November 25, 2013

Vanderbilt celebrates 18 elected fellows of the AAAS

Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.

By Bill Snyder
August 26, 2013

Tumor factor spurs blood vessel growth

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

By Leigh MacMillan
Campus aerials. (John Russell/Vanderbilt University)
October 17, 2012

Beauchamp, Vermund elected to Institute of Medicine

R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences, and Sten Vermund, M.D., Ph.D., director of the Vanderbilt Institute for Global Health, have been elected to the Institute of Medicine (IOM), the organization announced this week.

By Bill Snyder
March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

By VUMC News and Communications
October 7, 2011

Heart protein may be target for colon cancer therapies

A protein critical in heart development may also play a part in colon cancer progression.

By VUMC News and Communications